Carbutamide

This classification denotes an anti-diabetic agent with the molecular formula C11H17N3O3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) E3K8P4869P, chemically known as urea, 1-butyl-3-sulfanilyl- but more generally known as carbutamide, which bears US NIH Compound Identifier 9564. European Medicines Agency schedules Carbutamide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06620MIG. The term CARBUTAMIDE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 31, No10, 1977, List 17) WHO schedules carbutamide in its Anatomical Therapeutic Chemical (ATC) Classification. CARBUTAMIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule carbutamide under HS 29350090 and SITC 51580. As of Q4 2014, CARBUTAMIDE remains US FDA's Preferred Term for this commodity. Carbutamide bears US NLM identifiers UMLS ID C0007080 and NCI Concept Code C83597. SMILES: CCCCNC(=O)NS(=O)(=O)C1=CC=C(C=C1)N.